Eclipse Eying Profitability As Medicare TMR Reimbursement Comes On Line
This article was originally published in The Gray Sheet
Executive Summary
Eclipse Surgical Technologies is conducting three training programs per month at five U.S. centers in anticipation of Medicare reimbursement coverage for surgical transmyocardial revascularization (TMR) procedures, scheduled to take effect July 1, President and CEO Allen Hill reported June 7 at the Paine Webber 10th Annual Growth & Technology Conference in New York City.
You may also be interested in...
BlueCross BlueShield Assessment Okays Combined TMR/CABG Procedure
Transmyocardial revascularization (TMR) performed in conjunction with coronary artery bypass graft surgery on certain patients meet BlueCross BlueShield Association Technology Evaluation Center assessment criteria, according to an assessment summary.
BlueCross BlueShield Assessment Okays Combined TMR/CABG Procedure
Transmyocardial revascularization (TMR) performed in conjunction with coronary artery bypass graft surgery on certain patients meet BlueCross BlueShield Association Technology Evaluation Center assessment criteria, according to an assessment summary.
Laser Myocardial Therapies Under The Beam In Light Of J&J DIRECT Results
Results of a Johnson & Johnson-sponsored trial showing that direct myocardial revascularization (DMR) technology has a placebo-comparable effect should prompt FDA to take a closer look at laser therapies for advanced heart disease patients, trial investigators suggest.